Insider trades
Daniell Richard, EVP of Teva Pharmaceutical Industries TEVA, has filed 0 purchases and 28 sales on the open market. Over the past 12 months that comes to a net sale of $12.1M. The latest trade was on 05/05.
Daniell Richard
EVP, Europe Commercial
- First filing
- 23/02/09
- Trades
- 80 trades
- Buys / sales
- 0 / 28
- 12-month net buying
- −$12.1M
- Last trade
- 05/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/05 | 05/07 | 30,000 sh | $35.40 | $1,062,000 | −35.0% | |
| Open-market sale10b5-1 plan | 03/05 | 03/09 | 17,295 sh | $31.67 | $547,732.65 | −16.8% | |
TEVA | Open-market sale10b5-1 plan | 03/04 | 03/06 | 91,345 sh3 trades | $32.66avg. | $2,983,370.98 | −51.6% |
TEVA | Open-market sale10b5-1 plan | 03/03 | 03/05 | 128,985 sh2 trades | $32.36avg. | $4,173,954.6 | −51.2% |
| Open-market sale | 25/12/09 | 25/12/11 | 115,468 sh | $28.68 | $3,311,622.24 | −70.5% | |
TEVA | Open-market sale10b5-1 plan | 25/03/05 | 25/03/07 | 70,961 sh2 trades | $15.90avg. | $1,128,505.66 | −59.5% |
TEVA | Open-market sale10b5-1 plan | 25/03/04–25/03/05 | 25/03/06 | 140,372 sh6 trades | $15.79avg. | $2,216,829.08 | −59.2% |
TEVA | Open-market sale10b5-1 plan | 25/03/03–25/03/04 | 25/03/05 | 62,250 sh2 trades | $16.06avg. | $999,677.82 | −100.0% |
| Open-market sale | 24/08/12 | 24/08/13 | 98,943 sh | $17.30 | $1,711,713.9 | −100.0% | |
TEVA | Open-market sale10b5-1 plan | 24/03/05 | 24/03/07 | 48,629 sh2 trades | $13.52avg. | $657,464.08 | −33.0% |
TEVA | Open-market sale10b5-1 plan | 24/03/04 | 24/03/05 | 95,762 sh2 trades | $13.34avg. | $1,277,465.08 | −57.9% |
| Open-market sale10b5-1 plan | 24/02/28 | 24/03/01 | 20,599 sh | $13.12 | $270,258.88 | −22.8% | |
TEVA | Open-market sale | 23/03/06–23/03/07 | 23/03/08 | 72,009 sh2 trades | $9.55avg. | $688,045.87 | −50.8% |
TEVA | Open-market sale | 23/02/28 | 23/03/02 | 44,252 sh2 trades | $9.89avg. | $437,652.28 | −38.8% |